36 related articles for article (PubMed ID: 11257379)
1. Multisite intradermal antirabies vaccination. Immune responses in man and protection of rabbits against death from street virus by postexposure administration of human diploid-cell-strain rabies vaccine.
Nicholson KG; Prestage H; Cole PJ; Turner GS; Bauer SP
Lancet; 1981 Oct; 2(8252):915-8. PubMed ID: 6117693
[TBL] [Abstract][Full Text] [Related]
2. Pre-clinical toxicity & immunobiological evaluation of DNA rabies vaccine & combination rabies vaccine in rhesus monkeys (Macaca mulatta).
Kumar BD; Kumar PU; Krishna TP; Kalyanasundaram S; Suresh P; Jagadeesan V; Hariharan S; Naidu AN; Krishnaswamy K; Rangarajan PN; Srinivasan VA; Reddy GS; Sesikeran B
Indian J Med Res; 2013 Jun; 137(6):1072-88. PubMed ID: 23852288
[TBL] [Abstract][Full Text] [Related]
3. Long-term immunity and the effect of one or two booster doses with a lyophilized human rabies vaccine (human diploid cells) at 10 years post primary vaccination in China.
Hu J; Wang S; Zhou R; Liu H; Gan X; Wei M; Zhu F; Meng F; Hou W
Hum Vaccin Immunother; 2021 Sep; 17(9):3162-3168. PubMed ID: 33945439
[No Abstract] [Full Text] [Related]
4. Development of a novel multi-epitope oral DNA vaccine for rabies based on a food-borne microbial vector.
Ding Y; Gao Y; Chen R; Zhang Z; Li Q; Jia T; Zhang T; Xu R; Shi W; Chen L; Song Y; Han Q; Xia X; Song J; Zhang J
Int J Biol Macromol; 2024 Jan; 255():128085. PubMed ID: 37977454
[TBL] [Abstract][Full Text] [Related]
5. Laser-assisted skin delivery of immunocontraceptive rabies nanoparticulate vaccine in poloxamer gel.
Bansal A; Gamal W; Menon IJ; Olson V; Wu X; D'Souza MJ
Eur J Pharm Sci; 2020 Dec; 155():105560. PubMed ID: 32949750
[TBL] [Abstract][Full Text] [Related]
6. Systematic Booster after Rabies Pre-Exposure Prophylaxis to Alleviate Rabies Antibody Monitoring in Individuals at Risk of Occupational Exposure.
Parize P; Sommé J; Schaeffer L; Ribadeau-Dumas F; Benabdelkader S; Durand A; Tarantola A; Cailhol J; Goesch J; Kergoat L; Le Guern AS; Mousel ML; Dacheux L; Consigny PH; Fontanet A; Francuz B; Bourhy H
Vaccines (Basel); 2021 Mar; 9(4):. PubMed ID: 33805019
[TBL] [Abstract][Full Text] [Related]
7. Developments in Rabies Vaccines: The Path Traversed from Pasteur to the Modern Era of Immunization.
Natesan K; Isloor S; Vinayagamurthy B; Ramakrishnaiah S; Doddamane R; Fooks AR
Vaccines (Basel); 2023 Mar; 11(4):. PubMed ID: 37112668
[TBL] [Abstract][Full Text] [Related]
8. Extent of polymorphism and selection pressure on the
Arnal A; Villanueva-Lizama L; Teh-Poot C; Herrera C; Dumonteil E
Evol Appl; 2020 Dec; 13(10):2663-2672. PubMed ID: 33294015
[TBL] [Abstract][Full Text] [Related]
9. New Rabies Vaccines for Use in Humans.
Ertl HCJ
Vaccines (Basel); 2019 Jun; 7(2):. PubMed ID: 31226750
[TBL] [Abstract][Full Text] [Related]
10. Prevention and Immunotherapy of Secondary Murine Alveolar Echinococcosis Employing Recombinant EmP29 Antigen.
Boubaker G; Hemphill A; Huber CO; Spiliotis M; Babba H; Gottstein B
PLoS Negl Trop Dis; 2015; 9(6):e0003795. PubMed ID: 26053794
[TBL] [Abstract][Full Text] [Related]
11. The adaptation of a CTN-1 rabies virus strain to high-titered growth in chick embryo cells for vaccine development.
Guo C; Wang C; Luo S; Zhu S; Li H; Liu Y; Zhou L; Zhang P; Zhang X; Ding Y; Huang W; Wu K; Zhang Y; Rong W; Tian H
Virol J; 2014 May; 11():85. PubMed ID: 24885666
[TBL] [Abstract][Full Text] [Related]
12. Developments in rabies vaccines.
Hicks DJ; Fooks AR; Johnson N
Clin Exp Immunol; 2012 Sep; 169(3):199-204. PubMed ID: 22861358
[TBL] [Abstract][Full Text] [Related]
13. The cell biology of rabies virus: using stealth to reach the brain.
Schnell MJ; McGettigan JP; Wirblich C; Papaneri A
Nat Rev Microbiol; 2010 Jan; 8(1):51-61. PubMed ID: 19946287
[TBL] [Abstract][Full Text] [Related]
14. Replication-deficient rabies virus-based vaccines are safe and immunogenic in mice and nonhuman primates.
Cenna J; Hunter M; Tan GS; Papaneri AB; Ribka EP; Schnell MJ; Marx PA; McGettigan JP
J Infect Dis; 2009 Oct; 200(8):1251-60. PubMed ID: 19764884
[TBL] [Abstract][Full Text] [Related]
15. Rabies DNA vaccine: no impact of MHC class I and class II targeting sequences on immune response and protection against lethal challenge.
Kaur M; Rai A; Bhatnagar R
Vaccine; 2009 Mar; 27(15):2128-37. PubMed ID: 19356616
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy of Trypanosoma cruzi infection with DNA vaccines in mice.
Dumonteil E; Escobedo-Ortegon J; Reyes-Rodriguez N; Arjona-Torres A; Ramirez-Sierra MJ
Infect Immun; 2004 Jan; 72(1):46-53. PubMed ID: 14688079
[TBL] [Abstract][Full Text] [Related]
17. Post-exposure DNA vaccination protects mice against rabies virus.
Lodmell DL; Ewalt LC
Vaccine; 2001 Mar; 19(17-19):2468-73. PubMed ID: 11257379
[TBL] [Abstract][Full Text] [Related]
18. Rabies DNA vaccination of non-human primates: post-exposure studies using gene gun methodology that accelerates induction of neutralizing antibody and enhances neutralizing antibody titers.
Lodmell DL; Parnell MJ; Bailey JR; Ewalt LC; Hanlon CA
Vaccine; 2002 May; 20(17-18):2221-8. PubMed ID: 12009276
[TBL] [Abstract][Full Text] [Related]
19. Early rabies antibody response to intramuscular booster in previously intradermally immunized travelers using human diploid cell rabies vaccine.
Gherardin AW; Scrimgeour DJ; Lau SC; Phillips MA; Kass RB
J Travel Med; 2001; 8(3):122-6. PubMed ID: 11468113
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
